N-(2,6-Diisopropylphenylcarbamoylmethyl)iminodiacetic acid
CAS: 65717-97-7
Ref. 3D-FD22148
1g | 647.00 € | ||
2g | 986.00 € | ||
100mg | 186.00 € | ||
250mg | 310.00 € | ||
500mg | 436.00 € |
Product Information
- N-[2-[[2,6-bis(1-Methylethyl)phenyl]amino]-2-oxoethyl]-N-(carboxymethyl)glycineDisofeninDISIDA
- 2,2'-[(2-{[2,6-Di(Propan-2-Yl)Phenyl]Amino}-2-Oxoethyl)Imino]Diacetic Acid
- 2-[Carboxymethyl-[2-[2,6-di(propan-2-yl)anilino]-2-oxoethyl]amino]acetic acid
- Disida
- Disofenin
- Glycine, N-[2-[[2,6-bis(1-methylethyl)phenyl]amino]-2-oxoethyl]-N-(carboxymethyl)-
- N-(2,6-Diisopropylphenylcarbamoylmethyl)iminodiacetic Acid
- N-[2-[[2,6-Bis(1-methylethyl)phenyl]amino]-2-oxoethyl]-N-(carboxymethyl)glycine
- N-[[(2,6-Diisopropylphenyl)carbamoyl]methyl]iminodiacetic acid
N-(2,6-Diisopropylphenylcarbamoylmethyl)iminodiacetic acid is a monosodium salt that has been shown to be an inhibitor of the energy metabolism in cells. It is a structural analog of adenosine and inhibits the enzyme adenosine deaminase, which converts adenosine into inosine. Inhibiting this enzyme leads to increased levels of adenosine in the cell and causes depletion of ATP, resulting in cell death. N-(2,6-Diisopropylphenylcarbamoylmethyl)iminodiacetic acid has been shown to have therapeutic potential for autoimmune diseases such as primary sclerosing cholangitis (PSC). This compound also blocks T-cell activation and proliferation by inhibiting protein kinase C and cyclic AMP response element binding protein, leading to decreased inflammation.
N-(2,6-Diisopropylphenylcarbamoy
Chemical properties
Technical inquiry about: 3D-FD22148 N-(2,6-Diisopropylphenylcarbamoylmethyl)iminodiacetic acid
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.